At the Forefront in Fighting Cancer

Beyond Science 16. November 2017

This August, the US Food and Drug Administration (FDA) approved a new kind of drug which could well represent a breakthrough in cancer treatment. This medicine called Kymriah, a combination of immune and gene therapies, is destined for the treatment of pediatric acute lymphoblastic leukemia. The results so far have been impressive.

Achtung Sie verlassen diese Länder-Website.

At the Forefront in Fighting Cancer